Nothing new on Cochlear Limitedin the last three months. We read the news on it every day, write up anything that matters once a week, and tell you sooner if something can't wait. A quiet stretch is normal and is not a signal by itself.
Cochlear Limited analyst price targets
Average target$117+137%vs $49.45 today
TodayAvg price
Low $117High $117
Hold20 analysts
1Bearish
13Neutral
6Bullish
FirmRatingPrice TargetDate
RBC Capital
Sector Perform
$117
7/16/2026
Cochlear Limited earnings
Earnings history
EstimateBeatMiss
Metrics we are tracking
Metric
Expectations
Status
Gross Margin
Sustain a trend toward 74% over the next eight quarters
70.5% in FY2026
Implant Volume
Growth staying above 5% annually for the total patient base
60,000 units in FY2026
FCF Conversion
Free cash flow staying above 80% of underlying net profit
87% in FY2026
Upgrade Revenue
Sound processor sales growing faster than new implant sales
2% constant currency in FY2026
Stay on top of Cochlear Limited
Follow Cochlear Limited to get the latest and most important updates.